Peer-reviewed medical journal Online-first publishing model

Open access scholarly publishing

American Journal of Medical and Clinical Sciences

A clean, publisher-style platform for clinical science, evidence summaries, and online-first research dissemination.

Open Access Peer Reviewed Rapid Online First
Submit Manuscript About the Journal

Current publishing cycle

Editorial updates

Follow new and recently accepted papers as they move through the journal.

View current issue Online first
1.387 Impact factor
Open Access model

Article details

Bioactive compounds in Costus afer Ker Gawl leaves and stem fractions protect against calcium ion-induced mitochondrial membrane permeability transition

Godswill N. Anyasor, Efemena E. Obukohwo, Olanipekun O. Adenike

American Journal of Medical and Clinical Sciences 2017 Vol. 1 Issue 1 Pages 3-157
View DOI Download PDF

Abstract

Objective: Costus afer Ker Gawl is an African ethno-medicinal plant used as a therapeutic for the treatment of oxidative stress-related diseases. This study was designed to identify the most active fractions of C.afer leaves and stem against calcium(II) (Ca2+)-induced mitochondrial membrane permeability transition (MPT).
Methods: C.afer leaves and stem were extracted using 70% methanol and subsequently subjected to successive solvent partitioning method to separate it into hexane, ethyl acetate, n-butanol and aqueous fraction of C.afer leaves and stem. Rat liver mitochondrial fractions were isolated using differential centrifugation technique, and mitochondrial MPT was assessed using a spectrophotometric method.
Results: Data showed that n-butanol fractions of C.afer leaves and stem exhibited a significantly high inhibition of Ca2+-induced mitochondrial MPT than other test fractions and standard spermine.
Conclusion: n-butanol fractions of Costus afer leaves and stem possess bioactive compounds with chemoprotective activity against Ca2+-induced mitochondrial MPT. Furthermore, it is suggested that n-butanol fractions of C.afer leaves and stem could be harnessed for bioactive compounds that can be used in the treatment of mitochondria- associated neurodegenerative diseases.